500 patients67,039 observations150 daysLIVE

Patient P-03062

Synthetic patientONX-7 · Day 142 · 25–34 · F · baseline S11Open companion preview
Therapy response
Declining
Tolerance
Deteriorating
GI state
Improving
Inflammatory state
Favorable
Nutritional resilience
Improving
Discontinuation risk
10%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 ONX-7 startedBaseline state S11
  2. Day 14 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 14.

Primary contributors, last 14 days
  • Toxicity+12
  • GI instability-11
  • Nutritional resilience+9
  • Inflammatory activity-4
  • Treatment adherence-4

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients.

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Butyrate / short-chain fatty acid production 60
      • MicrobiomeButyrate capacity 41/100
      • MicrobiomeF. prausnitzii depleted
    • Drug metabolism and exposure 35
      • DNADPYD *2A → slower clearance
    • Inflammatory signalling 25
      • DNAIL6 -174 variant raises baseline inflammatory tone
    DNA
    Fictional pharmacogenomic panel
    • IL6 -174 G/C
      Higher inflammatory tone
    • DPYD *2A heterozygous
      Slower drug clearance
    • CYP2D6 Normal metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 2.3 · butyrate capacity 41/100
    • Akkermansia muciniphilaNormal
    • Faecalibacterium prausnitziiLow
    • Bacteroides fragilisNormal
    • Bifidobacterium longumLow
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    60 ms
    Sleep
    7.3 h
    Steps
    9,589
    Resting HR
    60 bpm
    Daily log: GI score 16, nutritional resilience 67, adherence 91.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Avoid known triggers for now: fried or oily food, dairy, alcohol
    What to do
    • Log the daily check-in; one line is enough
    • Keep the current walking rhythm
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the scheduled dose as agreed with your care team
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0336943%S18AD-05no change37
    P-0320442%S16AD-05improved48
    P-0303441%S14AD-05no change30
    P-0338040%S16AD-05improved34
    P-0342440%S12AD-05improved41
    P-0312239%S13AD-05no change40
    P-0310538%S12AD-05no change60
    P-0315838%S17AD-05no change37
    P-0311137%S07AD-05no change48
    P-0312937%S18AD-05no change32
    P-0335137%S07AD-05no change51
    P-0344137%S19AD-05improved37